Hani Profile Hani

A challenging presentation of pyrexia and macroscopic hematuria in a kidney transplant patient

  • Authors Details :  
  • Hani Muhammad Elgahwagi,  
  • Mohamed Osama Ezwaie,  
  • Najat Mustafa Aloshibi,  
  • Fatma Hassan Rugrug

Journal title : Libyan Journal of Medical Sciences

Publisher : Medknow

Print ISSN : 2588-9044

Page Number : 133

Journal volume : 4

Journal issue : 3

77 Views Case Report

Kidney transplant kidney transplant ( KTx) recipients have increased susceptibility to a spectrum of infections including; bacterial, viral, and fungal pathogens. Many factors contribute to their infection potential risk, in terms of their immunosuppressive state, that result in suppression of their B‑and T‑lymphocyte repertoire, also to consider certain donor and recipient‑related factors, that make them at risk of specific type of infectious complications. In addition kidney transplant patients tolerate poorly infections, which may adversely affect their graft function, by inducing glomerular injury, hence early diagnosis, directed therapy, and careful dosing of antimicrobial agents is of paramount importance in reducing patient’s morbidity and mortality. We report a kidney transplant patient, who received her live related kidney graft 7 years earlier (in 2013), she has been with stable graft function in most of her follow up period, until she presented with pyrexia, dyspnea and fatigue associated with deterioration of her graft function.

Article DOI & Crossmark Data

DOI : https://doi.org/10.4103/LJMS.LJMS_17_20

Article Subject Details


Article Keywords Details



Article File

Full Text PDF

Article References

  • (1). U S Renal Data System, USRDS 2010 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2010.
  • (2). Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr., Bolger AF, Levison ME, et al. Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals. American Heart Association; endorsed by the Infectious Diseases Society of America. Circulation 2005;111:e394-434.